On April 27, 2014, the 14th and final subject was enrolled in our nearly completed New Zealand observational study of ibogaine assisted treatment for opioid dependence. Since July 2012, Principal Investigator …
On January 11, 2013, Principal Investigator Geoff Noller, Ph.D., reported that our ongoing observational study of ibogaine treatment for opioid dependence in New Zealand had received an additional donation …
On January 9, 2013, the seventh participant was enrolled in our ongoing observational study of ibogaine treatment for addiction in New Zealand. The sixth subject was enrolled on December 8, 2012. This …
On November 9, 2012, the fifth participant was enrolled in our ongoing observational study of ibogaine treatment for addiction in New Zealand. All participants had been receiving methadone treatment for …
From October 2-6, 2012, the Global Ibogaine Therapist Alliance (GITA) conference in Vancouver, Canada, gathered international researchers and ibogaine treatment providers to discuss current science and …
On September 10, 2012, the 30th and final subject completed the 12-month follow-up in our observational study of ibogaine treatment for addiction in Mexico. This will be first long-term outcome study ever …
Between October 2-6th, 2012, the Global Ibogaine Therapist Alliance (GITA) will hold its 3rd international gathering of Ibogaine providers in Vancouver, BC, Canada. The conference will feature panels of …
On July 16, 2012, the first two participants were enrolled in our recently initiated observational study of ibogaine treatment for addiction in New Zealand. Both of these individuals are suffering from …
By: One News Television New Zealand MAPS’ observational study of ibogaine-assisted therapy for addiction treatment in New Zealand is the focus of a 10-minute segment on Television New Zealand. Study …
As of April 6, 2012, seven out 30 subjects had completed follow-up in our ongoing observational study of ibogaine treatment for addiction in Mexico. 19 out of 30 subjects are still in the follow-up portion …
On February 22, 2012, MAPS’ new observational study of ibogaine treatment for addiction in New Zealand received final approval (pdf) from the Multi-region Ethics Committee. The new study will take …
On January 12, 2012, the fourth subject completed follow-up in our ongoing observational study of ibogaine treatment for addiction in Mexico. 22 out of 30 subjects are still in the follow-up portion of …
